Published in Cancer Res on March 01, 1977
Mutated beta-actin gene: coexpression with an unmutated allele in a chemically transformed human fibroblast cell line. Proc Natl Acad Sci U S A (1981) 1.36
Classification of cultured mammalian cells by shape analysis and pattern recognition. Proc Natl Acad Sci U S A (1980) 0.89
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (1993) 15.54
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science (1989) 7.90
Chemical differentiation along metaphase chromosomes. Exp Cell Res (1968) 6.82
Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med (1997) 6.72
Identification of human chromosomes by DNA-binding fluorescent agents. Chromosoma (1970) 6.57
The 24 fluorescence patterns of the human metaphase chromosomes - distinguishing characters and variability. Hereditas (1972) 6.31
Formaldehyde fixation. J Histochem Cytochem (1985) 5.89
The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev (1996) 5.71
Cellular-telephone use and brain tumors. N Engl J Med (2001) 5.57
Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med (1996) 4.72
Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J Biomed Mater Res (1991) 3.57
Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst (1996) 3.52
Differential binding of alkylating fluorochromes in human chromosomes. Exp Cell Res (1970) 3.51
Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci U S A (1996) 3.38
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Analysis of human metaphase chromosome set by aid of DNA-binding fluorescent agents. Exp Cell Res (1970) 2.66
THE GENETIC CONTROL OF NUCLEOLAR COMPOSITION. Proc Natl Acad Sci U S A (1940) 2.66
Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst (1988) 2.47
Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst (1999) 2.38
Case-control study of canine malignant lymphoma: positive association with dog owner's use of 2,4-dichlorophenoxyacetic acid herbicides. J Natl Cancer Inst (1991) 2.36
Association between childhood acute lymphoblastic leukemia and use of electrical appliances during pregnancy and childhood. Epidemiology (1998) 2.33
Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst (1994) 2.31
The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J Biol Chem (2000) 2.28
Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science (1985) 2.23
Quantitative reflection contrast microscopy of living cells. J Cell Biol (1979) 2.22
Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene (1999) 2.19
XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis (2000) 2.16
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy. AIDS (1999) 2.09
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med (1988) 2.03
Increased hypermutation at G and C nucleotides in immunoglobulin variable genes from mice deficient in the MSH2 mismatch repair protein. J Exp Med (1998) 2.00
DNA-binding fluorochromes for the study of the organization of the metaphase nucleus. Exp Cell Res (1969) 1.95
Breast cancer trends of black women compared with white women. Arch Fam Med (1999) 1.91
Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol (1995) 1.91
Altered spectra of hypermutation in antibodies from mice deficient for the DNA mismatch repair protein PMS2. Proc Natl Acad Sci U S A (1998) 1.86
Test for malignant transformation of rat liver cells in culture: cytology, growth in soft agar, and production of plasminogen activator. J Natl Cancer Inst (1977) 1.86
Influence of oxygen and culture media on plating efficiency of some mammalian tissue cells. J Natl Cancer Inst (1972) 1.86
Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia? Am J Epidemiol (2000) 1.82
Cytochemical evaluation of metabolic inhibitors in cell culture. Exp Cell Res (1965) 1.80
Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health (2001) 1.80
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. J Clin Immunol (2001) 1.75
Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst (2001) 1.72
Latex gloves not enough to exclude viruses. Nature (1988) 1.70
G2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet (1985) 1.67
Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med (1990) 1.60
Statistical issues in interpretation of chronic bioassay tests for carcinogenicity. J Natl Cancer Inst (1979) 1.60
Chemical differentiation with fluorescent alkylating agents in Vicia faba metaphase chromosomes. Exp Cell Res (1969) 1.57
Using a clinical practice guideline to measure physician practice: translating a guideline for the management of heart failure. J Am Board Fam Pract (1997) 1.53
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2001) 1.51
Hereditary retinoblastoma and risk of lung cancer. J Natl Cancer Inst (2000) 1.51
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy. Nat Med (1998) 1.50
Papanicolaou smear screening and cervical cancer. What can you expect? JAMA (1984) 1.48
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. J Clin Invest (1997) 1.46
Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer (1996) 1.46
The use of fluorescence techniques for the recognition of mammalian chromosomes and chromosome regions. Int Rev Exp Pathol (1972) 1.45
Distinction between extra G-like chromosomes by quinacrine mustard fluorescence analysis. Exp Cell Res (1970) 1.44
Characteristics of and relationship between C particles and intracisternal A particles in cloned cell strains. J Virol (1968) 1.43
Four patients with trisomy 8 identified by the fluorescence and Giemsa banding techniques. J Med Genet (1972) 1.42
Alternate ranging methods for cancer mortality maps. J Natl Cancer Inst (2000) 1.41
Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines in vitro : quantitation of the cytotoxic reaction by release of tritiated thymidine from prelabeled target cells. J Natl Cancer Inst (1975) 1.38
Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis. Exp Cell Res (1970) 1.37
A quest for the mechanism of "spontaneous" malignant transformation in culture with associated advances in culture technology. J Natl Cancer Inst (1982) 1.36
Radiosensitivity in Huntington's disease: implications for pathogenesis and presymptomatic diagnosis. Lancet (1980) 1.32
Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes. Immunology (2001) 1.30
Radiation-induced non-random chromosome breakage. Exp Cell Res (1972) 1.30
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters. Proc Natl Acad Sci U S A (2001) 1.26
The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat Res (1996) 1.26
Chromatid damage after G2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc Natl Acad Sci U S A (1983) 1.24
Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Res (1984) 1.23
Tubulin and actin in paired nonneoplastic and spontaneously transformed neoplastic cell lines in vitro: fluorescent antibody studies. Cell (1978) 1.22
A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis (2000) 1.21
Formaldehyde and cancer risk: a quantitative review of cohort studies through 2006. Ann Oncol (2007) 1.19
Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitis. Hum Pathol (1992) 1.19
Factors affecting and significance of G2 chromatin radiosensitivity in predisposition to cancer. Int J Radiat Biol (1989) 1.18
Oral health status of the elderly in New England. J Gerontol (1993) 1.17
DNA repair proficiency: potential susceptiblity factor for breast cancer. J Natl Cancer Inst (1996) 1.17
On the possible role of involution in the natural history of breast cancer. Cancer (1993) 1.16
Translocations causing non-fluorescent Y chromosomes in human XO/XY mosaics. Hereditas (1971) 1.16
Innovation in medical diagnosis--the Scandinavian curiosity. Lancet (1979) 1.16
Fluorescent labeling of chromosomal DNA: superiority of quinacrine mustard to quinacrine. Science (1970) 1.16
Virus particles and murine leukemia virus complement-fixing antigen in neoplastic and nonneoplastic cell lines. Science (1967) 1.14
cDNA cloning of the B cell membrane protein CD22: a mediator of B-B cell interactions. J Exp Med (1991) 1.13
Magnetic field exposure assessment in a case-control study of childhood leukemia. Epidemiology (1997) 1.13
Involution and the etiology of breast cancer. Cancer (1994) 1.12
Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol (1990) 1.12
Computerized chromosome identification by aid of the quinacrine mustard fluorescence technique. Hereditas (1972) 1.12
Do confounding or selection factors of residential wiring codes and magnetic fields distort findings of electromagnetic fields studies? Epidemiology (2000) 1.11
The relation between score tests and approximate UMPU tests in exponential models common in biometry. Biometrics (1983) 1.08
Increased lymphocyte replicative index following 2,4-dichlorophenoxyacetic acid herbicide exposure. Cancer Causes Control (2000) 1.08
Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa. J Exp Med (1994) 1.07
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS (1999) 1.07
Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes. Blood (1993) 1.06
Influence of oxygen and pH on plating efficiency and colony development of WI-38 and Vero cells. Exp Cell Res (1974) 1.06
Biologic behavior of dysplasia and carcinoma in situ. Am J Obstet Gynecol (1967) 1.06
Identification of different Robertsonian translocations in man by quinacrine mustard fluorescence analysis. Hereditas (1971) 1.06
Case-control study of childhood acute lymphoblastic leukemia and residential radon exposure. J Natl Cancer Inst (1998) 1.05
False-positive and false-negative rates for carcinogenicity screens. Cancer Res (1977) 1.05
Identification of the abnormal B group chromosome in the "cri du chat" syndrome by QM-fluorescence. Exp Cell Res (1970) 1.05